| Accession Number | 0002010019-26-000024 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 6, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 410 | $267.99 | $109,875.61 | 132,019 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 300 | $259.98 | $77,994.00 | 131,719 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 200 | $261.49 | $52,297.50 | 131,519 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 947 | $263.94 | $249,952.60 | 130,572 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 192 | $265.27 | $50,932.80 | 130,380 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 1,233 | $267.79 | $330,181.25 | 129,147 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Aug 3, 2026 | Sale | 128 | $268.70 | $34,393.14 | 129,019 | Direct | โ | View Details |